Best Bank Stocks: 17.68% gain in 30 trading days

Best tech stocks prediction from May 23rd 2014 (before market opening) based on "I Know First" predictive Algorithm. This forecast is designed for investors and analysts who need predictions of the best performing stocks for a specific industry: Best Bank Stocks
  • Time horizon of the forecast: 30 trading days from May 23rd 2014.
Bank Stocks (May23) 1months I Know First predicts daily the best performing stocks per industry. The stocks in this forecast are our Best Bank Stocks . Other industries include: Health Care, Tech, Automotive, Consumer Products, etc.. Don't see your industry of interest? To recieve your customized industry forecast, email:[email protected]

Best Tech Stocks Based on Predictive Analytics: 15.78% gain in 30 days

Best tech stocks prediction from May 23rd 2014 (before market opening) based on "I Know First" predictive analytics. This forecast is designed for investors and analysts who need predictions of the best performing stocks for a specific industry: Best Tech Stocks
  • Time horizon of the forecast: 30 trading days from May 23rd 2014 - June 23rd 2014.
Tech Stocks (may23)1month

Black-Box Trading: 15.70% Gain in 30 Days

Stock forecast based on predictive algorithms: the forecast for the Top 10 aggressive stocks based on "I Know First" stock forecast algorithm. The stock forecast includes predictions for:
  • The top 10 stocks to buy (aggressive) that best fit for long position.
  • Forecast date: May 23rd 2014
  • Time horizon of the forecast: 30 trading days from May 23rd - June 23rd 2014.
Top 10 Aggressive (may23) 30 days Get today's aggressive stock picks  What are the aggressive stock picks? We screen our database daily for higher volatility stocks that recently moved often strongly up or down . These aggressive stocks present more opportunities, but are also more risky.

I Know First Review: June 18th 2014

The stocks selected here are the top performing stocks from I Know First: Daily Market Forecast’s May 18th 2014 Stock Forecast titled, Stock Forecast Based on Predictive Algorithms: 10.07% Average Gain In 30 Days. The "I Know First Average" return was 10.07% versus the S&P 500’s return of 4.21% over the same time period. Top 10 Aggressive (may 18 )month

Top Ten Small-Cap Stocks: 8.13% Average Gain in 30 Days

op 10 small-cap stock picks based on algorithms: the forecast for the Top 10 small-cap stocks from May 21st(before market opening) are based on the "I Know First" stock forecast algorithm.
  • The stock forecast includes predictions for:
  • The Top 10 small-cap stock picks that best fit for long position.
  • Forecast date: May 21st
  • Time horizon of the forecast: 30 trading days from May 21st 2014 - June 21st 2014
Top 10 small caps (may21) 1 month

Capital Gains Based On Algorithms: 57.31% Average Gain in 1 Year

Capital gains based on algorithms: Forecast for the Top 10 aggressive stocks based on "I Know First" stock forecast algorithm. The stock forecast includes predictions for:
  • The top 10 stocks to buy (aggressive) that best fit for long position.
  • Forecast date: June 21st 2013
  • Time horizon of the forecast: 365 trading days from June 21st 2013 - June 21st 2014.
Top 10 Aggressive (21st June)

Algorithmic Market Check-Up: Pfizer

News about Pfizer's (PFE) failed pursuit of AstraZenca dominated the headlines last month, however this premium biopharmaceutical company can still be an attractive investment. Growth over the past few years has been steady and the current balance sheet is salubrious, allowing the company to take advantage of new opportunities that arise. If this opportunity is not created through an acquisition, Pfizer's new research center in Kendall Square, Cambridge, Massachusetts is experimenting with a new approach to conducting research, which may be just what the company needs. mishkefet The 280,000-foot facility will have open working spaces, and encourage sharing ideas with their academic and biotech neighbors. Senior vice president Jose-Carlos Gutiérrez-Ramos downplayed the risk of eavesdropping by competitors stating, "there are a few things - the chemical structure of a drug or the protein sequence of a therapeutic antibody - where we need to take precautions… However, those are only 10 percent of our activity. The other 90 percent can be shared."